Synergistic Role of Protein Phosphatase Inhibitor 1 and Sarco/Endoplasmic Reticulum Ca 2+ -ATPase in the Acquisition of the Contractile Phenotype of Arterial Smooth Muscle Cells
Author(s) -
Larissa Lipskaia,
Régis Bobe,
Jiqiu Chen,
Irene C. Turnbull,
José J. López,
Elise Merlet,
Dongtaq Jeong,
Ioannis Karakikes,
Alexandra S. Ross,
Lifan Liang,
Nathalie Mougenot,
Fabrice Atassi,
AnneMarie Lompré,
Sima T. Tarzami,
Jason C. Kovacic,
Evangelia G. Kranias,
Roger J. Hajjar,
Lahouaria Hadri
Publication year - 2013
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.113.002565
Subject(s) - phospholamban , endoplasmic reticulum , vascular smooth muscle , microbiology and biotechnology , medicine , endocrinology , myocardin , phosphatase , biology , phosphorylation , biochemistry , gene expression , serum response factor , smooth muscle , gene
Phenotypic modulation or switching of vascular smooth muscle cells from a contractile/quiescent to a proliferative/synthetic phenotype plays a key role in vascular proliferative disorders such as atherosclerosis and restenosis. Although several calcium handling proteins that control differentiation of smooth muscle cells have been identified, the role of protein phosphatase inhibitor 1 (I-1) in the acquisition or maintenance of the contractile phenotype modulation remains unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom